Exact Sciences (NASDAQ:EXAS – Free Report) had its price target cut by Robert W. Baird from $70.00 to $67.00 in a research note issued to investors on Wednesday morning, Benzinga reports. They currently have an outperform rating on the medical research company’s stock. Several other analysts have also weighed in on the company. Wells Fargo […]

Louisiana-Pacific (NYSE:LPX – Get Free Report) had its target price lifted by The Goldman Sachs Group from $90.00 to $99.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has a “sell” rating on the building manufacturing company’s stock. The Goldman Sachs Group’s price objective would suggest a potential downside of 6.97% from […]

Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target dropped by research analysts at The Goldman Sachs Group from $75.00 to $65.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the medical research company’s stock. The Goldman Sachs Group’s target price would suggest a […]